Jefferies Financial Group Inc. (JEF)

NYSE: JEF · Real-Time Price · USD
53.23
+0.74 (1.41%)
Nov 18, 2025, 4:00 PM EST - Market closed
1.41%
Market Cap10.98B
Revenue (ttm)7.23B
Net Income (ttm)646.47M
Shares Out 206.28M
EPS (ttm)2.92
PE Ratio18.39
Forward PE13.23
Dividend$1.60 (3.05%)
Ex-Dividend DateNov 17, 2025
Volume2,324,012
Open52.09
Previous Close52.49
Day's Range51.51 - 54.27
52-Week Range39.28 - 82.68
Beta1.50
AnalystsBuy
Price Target71.00 (+33.38%)
Earnings DateJan 7, 2026

About JEF

Jefferies Financial Group Inc. operates as an investment banking and capital markets firm in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Investment Banking and Capital Markets, and Asset Management. It provides investment banking, advisory services with respect to mergers or acquisitions, debt financing, restructurings or recapitalizations, and private capital advisory transactions; underwriting and placement services related to corporate debt, municipal debts, mortgage-backed and asset-bac... [Read more]

Sector Financials
Founded 1968
Employees 7,822
Stock Exchange NYSE
Ticker Symbol JEF
Full Company Profile

Financial Performance

In 2024, Jefferies Financial Group's revenue was $7.01 billion, an increase of 49.15% compared to the previous year's $4.70 billion. Earnings were $669.27 million, an increase of 156.48%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for JEF stock is "Buy." The 12-month stock price target is $71.0, which is an increase of 33.38% from the latest price.

Price Target
$71.0
(33.38% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Saga Diagnostics to Present at Jefferies Global Healthcare Conference in London

MORRISVILLE, N.C.--(BUSINESS WIRE)-- #JefferiesHealthcare--Presentation will focus on its flagship MRD assay, Pathlight, accompanied by a commercial update following its favorable Medicare coverage.

21 hours ago - Business Wire

Vicore to Present at The Jefferies Global Healthcare Conference in London

STOCKHOLM, SE / ACCESS Newswire / November 17, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), t...

2 days ago - Accesswire

JEFFERIES INVESTORS: Jefferies Financial Group Inc. (JEF) is being Investigated for Securities Fraud, Investors are Urged to Contact BFA Law

New York, New York--(Newsfile Corp. - November 14, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point B...

4 days ago - Newsfile Corp

Medincell Management to Participate in Fireside Chat at the Jefferies London Healthcare Conference 2025 (London - Nov. 17-20, 2025)

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Christophe Douat, Chief Executive Officer, and Dr. Richard Malamut, Chief Medical Officer, will present Medincell's (Paris:MEDCL) corporate overv...

5 days ago - Business Wire

Keenova to Participate in the Jefferies Global Healthcare Conference in London

DUBLIN , Nov. 12, 2025 /PRNewswire/ -- Keenova Therapeutics plc ("Keenova" or the "Company") today announced that management will present at the Jefferies Global Healthcare Conference in London on Wed...

6 days ago - PRNewsWire

Beacon Therapeutics to Participate in the Jefferies Global Healthcare Conference

LONDON and CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics' or ‘the Company'), a leading clinical-stage biotechnology company with a miss...

6 days ago - GlobeNewsWire

AdvanCell to participate in Jefferies Global Healthcare Conference in London

SYDNEY--(BUSINESS WIRE)-- #JefferiesGlobalHealthcareConference--AdvanCell to share positive 212Pb-ADVC001 results and US expansion updates at the Jefferies Global Healthcare Conference in London (17–2...

7 days ago - Business Wire

Aqemia to Participate in the Jefferies Global Healthcare Conference 2025

LONDON--(BUSINESS WIRE)--Aqemia, a pioneering TechBio company combining generative AI and quantum-inspired physics to invent drugs, announces that Maximilien Levesque, CEO and co-founder, and Théa Vu-...

8 days ago - Business Wire

Autobahn Therapeutics to Participate in 2025 Jefferies London Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced tha...

8 days ago - Business Wire

JEF STOCK NOTICE: Jefferies Financial Group Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law

New York, New York--(Newsfile Corp. - November 10, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point B...

8 days ago - Newsfile Corp

JEFFERIES INVESTIGATION: Jefferies Financial Group Inc. (NYSE:JEF) Investors with Losses are Notified of the Pending Securities Fraud Investigation – Contact BFA Law

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...

13 days ago - GlobeNewsWire

Secura Bio to Participate in the Jefferies Global Healthcare Conference in London

BERKELEY HEIGHTS, N.J., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Secura Bio, Inc. (www.securabio.com), an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announ...

13 days ago - GlobeNewsWire

JEF INVESTOR REMINDER: Jefferies Financial Group Inc. Investors may have been Affected by Fraud -- Contact BFA Law if You Suffered Losses

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...

15 days ago - GlobeNewsWire

JEFFERIES INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Urges Jefferies Stockholders to Contact the Firm Regarding their Rights

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Jefferies (JEF) To Contact Him Directly To Discuss Their Options If you purchased or acquir...

17 days ago - GlobeNewsWire

JEFFERIES INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation into Jefferies Financial Group Inc. on Behalf of Jefferies Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Jefferies (JEF) To Contact Him Directly To Discuss Their Options If you purchased or acquir...

21 days ago - GlobeNewsWire

Laxxon Medical to Attend BIO-Europe and Jefferies Healthcare Conference World Premier Life Science Partnering Events

NEW YORK--(BUSINESS WIRE)--Laxxon announces attendance at BIO-Europe and Jefferies Healthcare Conference.

22 days ago - Business Wire

JEF INVESTIGATION: Investigation Launched into Jefferies Financial Group Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Firm - RGRD

SAN DIEGO, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The firm of  Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Jefferies Financial Group Inc...

25 days ago - GlobeNewsWire

JEF INVESTORS: Jefferies Financial Group Inc. Hit with Securities Fraud Investigation after Stock Plummets 8% -- Investors Urged to Contact BFA Law

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital f...

25 days ago - GlobeNewsWire

Jefferies Financial Group, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Jefferies Financial Group, Inc., ("Jefferies" or the "Company") (NYSE: JEF) investors that the firm has initiated an investi...

26 days ago - GlobeNewsWire

Jefferies Financial Group Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - JEF

LOS ANGELES , Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Jefferies Financial Group Inc. ("Jefferies" or "the Company") (NYSE: J...

27 days ago - PRNewsWire

JEF Investors Have Opportunity to Join Jefferies Financial Group Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES , Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Jefferies Financial ...

27 days ago - PRNewsWire

JEF STOCK NOTICE: Jefferies Financial Group Inc. Investors with Losses may have been Affected by Securities Fraud – Contact BFA Law about its Pending Investigation

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital ...

27 days ago - GlobeNewsWire

Smarsh Announces Expansion of Relationship with Jefferies

PORTLAND, Ore.--(BUSINESS WIRE)--Today, Smarsh announced that Jefferies has selected the company's flagship communications surveillance technology to address the growing challenge of monitoring vast a...

4 weeks ago - Business Wire

Jefferies Earns Upgrade After Recent Dip, As M&A Momentum Expected To Continue

Jefferies Financial (JEF) is upgraded to a buy from my prior 2 hold ratings, agreeing with today's Wall St consensus, despite a difficult week in the media for banks. M&A and asset management momentum...

4 weeks ago - Seeking Alpha

RGRD Launches Investigation into Jefferies Financial Group, Inc. and Encourages Investors and Potential Witnesses to Contact Firm

SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The firm of  Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Jefferies Financial Group Inc...

4 weeks ago - GlobeNewsWire